Mission Science Research Who we serve Get in touch
Wellness innovation

Where empathy meets the science of feeling well.

Mythos Labs is a health and wellness company building clinically-informed solutions for people navigating the complex realities of modern metabolic therapy — rooted in evidence, designed for real life.

Partner with us Our approach
GLP-1 users in the US
9M+
growing 40% year over year
Expanding market
Experience significant side effects
70%
with limited purpose-built support
Unmet need
Discontinue within 6 months
1 in 3
often due to manageable side effects
Our mission
Our purpose

Science that supports the whole person

GLP-1 medications are transforming lives. We exist to ensure the journey is comfortable, informed, and sustainable — for every person on that path.

Clinically grounded

Every decision we make begins with peer-reviewed evidence and clinical insight — not wellness trends or marketing convenience.

Patient-first design

We listen deeply to real patients. Our approach is shaped by what people actually experience — not what we assume they need.

Transparent by nature

We earn trust through proof. Full ingredient disclosure, third-party verification, and no borrowed claims — ever.

A gap no one has filled — until now.

Millions of people on GLP-1 therapy face real, manageable challenges with no purpose-built support. Mythos Labs was founded to change that — with solutions grounded in science and designed around real human experience.

70%
of GLP-1 patients experience gastrointestinal side effects, particularly in early months of therapy
$0
worth of purpose-built, clinically-informed support products exist specifically for this patient population today
1 in 3
patients reduce or discontinue therapy within six months — often due to side effects that could be addressed
Scientific foundation

Warm care, built on hard evidence

The best wellness products feel human — and are built on rigorous science. At Mythos Labs, these are not in tension. They are inseparable.

Our development process is guided by a multidisciplinary team of clinicians, researchers, and patient advocates who understand both the data and the lived experience.

Peer-reviewed ingredient selection
Active ingredients chosen exclusively on published clinical evidence — no proprietary blends.
Third-party tested, every batch
Potency, purity, and contaminant testing by independent accredited laboratories.
cGMP-certified manufacturing
Produced in FDA-registered, cGMP-compliant facilities. No shortcuts on quality or compliance.
Clinical advisory oversight
Prescribers, registered dietitians, and specialists review all formulations and claims.
Mythos Performance
A division of Mythos Labs
Research division

Mythos Performance

Our in-house research group, Mythos Performance, drives the evidence foundation behind everything we build. The team conducts and synthesizes clinical research focused on the intersection of metabolic health, GI function, and human performance.

Mythos Performance partners with academic institutions, clinical practices, and patient advocacy groups to ensure our work reflects the highest standards of scientific inquiry — and the real needs of the people we serve.

Metabolic health research GI function studies Clinical partnerships Patient outcomes Formulation science
Who we serve

Built for everyone in the ecosystem

You deserve to feel well on your journey

GLP-1 therapy is working — but the experience can be hard. Mythos Labs is building alongside you, with solutions designed for what you're actually going through.

  • Designed for real GLP-1 experiences, not generic wellness
  • Formats built for low appetite and sensitive digestion
  • Clean, honest formulations — nothing hidden
  • Developed to complement your medication, not compete with it
"I just want something that helps me feel human again while the medication does its job."
— GLP-1 patient, Mythos Performance research interview

A company you can confidently stand behind

We understand the scrutiny practitioners apply to supplement recommendations. Mythos Labs is built for exactly that scrutiny — transparent, evidence-based, and drug-interaction aware.

  • Substantiation dossiers available for all claims
  • Formulated with awareness of GLP-1 pharmacology
  • HCP engagement and sampling programs in development
  • Telehealth and clinical integration partnerships underway
  • Guided by Mythos Performance clinical advisory board
"If there were a product I could actually stand behind for my GLP-1 patients, I'd recommend it at every visit."
— Prescriber advisory feedback, Mythos Performance

First-mover in an urgent, underserved category

The GLP-1 market is the fastest-growing pharmaceutical category in history. No dedicated companion wellness brand holds this space. Mythos Labs is positioned to define it.

  • 9M+ US GLP-1 users growing 40% year over year
  • No established competitor in this specific category
  • Multi-channel strategy: DTC, retail, telehealth, HCP
  • Strong margin profile with subscription-first model
  • Research credibility via Mythos Performance division
"No brand currently owns the GI support for GLP-1 users positioning. First-mover advantage creates a defensible market position."
— Mythos Labs internal market analysis

Stay close to what we're building

Whether you're a patient, prescriber, investor, or potential partner — we'd love to hear from you at team@mythoslabs.net or use the form below.

We read every message and respond personally.

Message received

Thank you for reaching out. Someone from the Mythos Labs team will be in touch at shortly.